Matches in SemOpenAlex for { <https://semopenalex.org/work/W2286974098> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2286974098 endingPage "10550" @default.
- W2286974098 startingPage "10550" @default.
- W2286974098 abstract "10550 Background: Prostaglandin E2 plays a growth stimulatory role in breast cancer; and the rate-limiting enzyme in its synthesis, cyclooxygenase-2 (COX-2), is over-expressed in breast cancers. However, little is known about the expression pattern and activities of the key prostaglandin catabolic enzyme PGDH, in breast cancer pathogenesis. Methods: 5-aza-2’-deoxycytidine and suberoyl anilide bishydroxamide (SAHA) were used to unmask epigenetically silenced genes. DNA and RNA were extracted from tumors and cell lines using standard methods, and bisulfite sequencing was used for methylation analysis. Western blotting and real time PCR were used for expression analysis, and PGDH expression vector and PGDH-directed siRNA were used for overexpression and downregulation of PGDH, respectively. Athymic mice were utilized for xenograft models. Results: Using a pharmacologically based, genome-wide screen for epigenetically silenced genes, we found low levels of PGDH in MDA-MB-231 cells (estrogen receptor- (ER) and HER2-negative), but high levels in MCF-7 cells (ER-positive, HER2-negative), and observed upregulation of this enzyme following demethylation treatment. Methylation analysis revealed methylation of the PGDH promoter in one breast cancer cell line and in 3 of 10 primary tumors. Analysis of PGDH expression demonstrated low levels in 40% of primary breast tumors and identified a correlation between PGDH and ER expression. Upregulation of PGDH levels in MDA-MB-231 cells decreased their clonal growth and reduced their ability to form tumors in athymic mice. In contrast, silencing of PGDH in MCF-7 cells increased proliferation and enhanced in-vivo tumorigenicity. Further analysis revealed upregulation of aromatase following silencing of PGDH and inhibition of the ER pathway by forced expression of the enzyme. PGDH levels were downregulated by estrogen but upregulated by the tumor suppressor gene C/EBPα. Conclusions: Our results identify for the first time, that PGDH, the COX-2 antagonist, is aberrantly silenced in breast cancer. Activation of this enzyme, particularly in ER- and HER2-negative tumors, now becomes an interesting target for clinical studies. No significant financial relationships to disclose." @default.
- W2286974098 created "2016-06-24" @default.
- W2286974098 creator A5001891565 @default.
- W2286974098 creator A5022311318 @default.
- W2286974098 creator A5039499748 @default.
- W2286974098 creator A5074015604 @default.
- W2286974098 creator A5082903377 @default.
- W2286974098 creator A5082910041 @default.
- W2286974098 creator A5082993956 @default.
- W2286974098 creator A5083392542 @default.
- W2286974098 date "2006-06-20" @default.
- W2286974098 modified "2023-09-24" @default.
- W2286974098 title "15-Hydroxyprostaglandin dehydrogenase (PGDH) is an aberrant tumor suppressor in human breast cancer" @default.
- W2286974098 doi "https://doi.org/10.1200/jco.2006.24.18_suppl.10550" @default.
- W2286974098 hasPublicationYear "2006" @default.
- W2286974098 type Work @default.
- W2286974098 sameAs 2286974098 @default.
- W2286974098 citedByCount "0" @default.
- W2286974098 crossrefType "journal-article" @default.
- W2286974098 hasAuthorship W2286974098A5001891565 @default.
- W2286974098 hasAuthorship W2286974098A5022311318 @default.
- W2286974098 hasAuthorship W2286974098A5039499748 @default.
- W2286974098 hasAuthorship W2286974098A5074015604 @default.
- W2286974098 hasAuthorship W2286974098A5082903377 @default.
- W2286974098 hasAuthorship W2286974098A5082910041 @default.
- W2286974098 hasAuthorship W2286974098A5082993956 @default.
- W2286974098 hasAuthorship W2286974098A5083392542 @default.
- W2286974098 hasConcept C104317684 @default.
- W2286974098 hasConcept C119056186 @default.
- W2286974098 hasConcept C121608353 @default.
- W2286974098 hasConcept C126322002 @default.
- W2286974098 hasConcept C127561419 @default.
- W2286974098 hasConcept C150194340 @default.
- W2286974098 hasConcept C153911025 @default.
- W2286974098 hasConcept C175211621 @default.
- W2286974098 hasConcept C189235521 @default.
- W2286974098 hasConcept C190727270 @default.
- W2286974098 hasConcept C33288867 @default.
- W2286974098 hasConcept C502942594 @default.
- W2286974098 hasConcept C530470458 @default.
- W2286974098 hasConcept C55493867 @default.
- W2286974098 hasConcept C62112901 @default.
- W2286974098 hasConcept C71924100 @default.
- W2286974098 hasConcept C84606932 @default.
- W2286974098 hasConcept C86803240 @default.
- W2286974098 hasConceptScore W2286974098C104317684 @default.
- W2286974098 hasConceptScore W2286974098C119056186 @default.
- W2286974098 hasConceptScore W2286974098C121608353 @default.
- W2286974098 hasConceptScore W2286974098C126322002 @default.
- W2286974098 hasConceptScore W2286974098C127561419 @default.
- W2286974098 hasConceptScore W2286974098C150194340 @default.
- W2286974098 hasConceptScore W2286974098C153911025 @default.
- W2286974098 hasConceptScore W2286974098C175211621 @default.
- W2286974098 hasConceptScore W2286974098C189235521 @default.
- W2286974098 hasConceptScore W2286974098C190727270 @default.
- W2286974098 hasConceptScore W2286974098C33288867 @default.
- W2286974098 hasConceptScore W2286974098C502942594 @default.
- W2286974098 hasConceptScore W2286974098C530470458 @default.
- W2286974098 hasConceptScore W2286974098C55493867 @default.
- W2286974098 hasConceptScore W2286974098C62112901 @default.
- W2286974098 hasConceptScore W2286974098C71924100 @default.
- W2286974098 hasConceptScore W2286974098C84606932 @default.
- W2286974098 hasConceptScore W2286974098C86803240 @default.
- W2286974098 hasIssue "18_suppl" @default.
- W2286974098 hasLocation W22869740981 @default.
- W2286974098 hasOpenAccess W2286974098 @default.
- W2286974098 hasPrimaryLocation W22869740981 @default.
- W2286974098 hasRelatedWork W1519915707 @default.
- W2286974098 hasRelatedWork W1971238663 @default.
- W2286974098 hasRelatedWork W1990232189 @default.
- W2286974098 hasRelatedWork W2140441381 @default.
- W2286974098 hasRelatedWork W2296384492 @default.
- W2286974098 hasRelatedWork W2417387999 @default.
- W2286974098 hasRelatedWork W2540716486 @default.
- W2286974098 hasRelatedWork W2618295127 @default.
- W2286974098 hasRelatedWork W2911855642 @default.
- W2286974098 hasRelatedWork W3194760749 @default.
- W2286974098 hasVolume "24" @default.
- W2286974098 isParatext "false" @default.
- W2286974098 isRetracted "false" @default.
- W2286974098 magId "2286974098" @default.
- W2286974098 workType "article" @default.